Patent · US Expired

Detection and modulation of IAPS for the diagnosis and treatment of proliferative disease

US6107041A · kind A · utility

16Cited by
1References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 1998
Grant dateAug 22, 2000
Priority date
Expiry dateDec 16, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/136
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids IAP fragments, and antibodies which specifically bind IAP polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.